Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 05, 2016 08:00 ET | Source: Evoke Pharma, Inc.

Evoke Pharma Schedules Webcast and Conference Call for First Quarter 2016 Financial Results

SOLANA BEACH, Calif., May 05, 2016 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced...
May 03, 2016 07:30 ET | Source: Evoke Pharma, Inc.

Evoke Announces Timing of Phase 3 Results from its Recently Fully Enrolled Pivotal Clinical Trial of EVK-001

SOLANA BEACH, Calif., May 03, 2016 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ:EVOK) today announced that it expects to provide top line data results from its pivotal Phase 3 clinical trial of...
April 25, 2016 08:00 ET | Source: Evoke Pharma, Inc.

Evoke Successfully Completes Phase 3 Clinical Trial Enrollment of EVK-001 in Women with Symptoms Associated with Diabetic Gastroparesis

SOLANA BEACH, Calif., April 25, 2016 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ:EVOK), today announced that it has successfully completed patient enrollment in its pivotal Phase 3 clinical...
March 10, 2016 16:05 ET | Source: Evoke Pharma, Inc.

Evoke Pharma Reports Fourth Quarter and Year End 2015 Results

SOLANA BEACH, Calif., March 10, 2016 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today...
March 04, 2016 08:30 ET | Source: Evoke Pharma, Inc.

Evoke Pharma Schedules Webcast and Conference Call for Fourth Quarter and Year End 2015 Financial Results

SOLANA BEACH, Calif., March 04, 2016 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today...
March 03, 2016 08:30 ET | Source: Evoke Pharma, Inc.

Evoke Accelerates New Drug Application Process by Engaging Regulatory Experts

SOLANA BEACH, Calif., March 03, 2016 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today...
March 01, 2016 08:30 ET | Source: Evoke Pharma, Inc.

Evoke Nears Completion of Phase 3 Clinical Trial Enrollment and Secures Extension to Credit Facility

SOLANA BEACH, Calif., March 01, 2016 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today...
February 17, 2016 08:30 ET | Source: Evoke Pharma, Inc.

Evoke Pharma to Present Results From Successful Thorough ECG (TQT) Study of EVK-001 at Digestive Disease Week 2016

SOLANA BEACH, Calif., Feb. 17, 2016 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today...
November 12, 2015 16:05 ET | Source: Evoke Pharma, Inc.

Evoke Pharma Reports Third Quarter 2015 Results

SOLANA BEACH, Calif., Nov. 12, 2015 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced...
November 10, 2015 08:30 ET | Source: Evoke Pharma, Inc.

Evoke to Participate in the Brean Capital 2015 Life Sciences Summit

SOLANA BEACH, Calif., Nov. 10, 2015 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced...